This is the reason interview with Nick Gillespie.

You've probably heard about microdosing, which involves taking a small subperceptual dose

of psychedelics like LSD or psilocybin on a regular basis to ward off depression, anxiety, and chronic pain,

or to optimize focus and boost energy.

My guests today are James Faderman and Jordan Gruber, authors of the new

book, Microdosing for Health Healing and Enhanced Performance. Jim Fadamon is a Stanford-trained

research psychologist who's been working with psychedelics since the early 1960s. He popularized

the concept of microdosing over a decade ago.

We talk about the mechanics of and the theory behind microdosing, its promise and its

limits, and how it fits into the larger psychedelic renaissance that's been flowering for most

of the 21st century.

We also discuss the prospects for legalization of, or at least cultural

normalization of psychedelics under the Trump administration. Here is the Reason interview with Jim

Fateman and Jordan Gruber. Jim Fateman, Jordan Gruber, thanks for talking to Reason.

Thanks for letting us talk to you.

Happy to be here.

So the book is microdosing for health healing and enhanced performance.

I think there's a, in a fractured America, there is a consensus that health healing and enhanced

performance are good things. Let's start with the basics. Can you, Jim, maybe since you

mainstreamed or popularized the idea of microdosing, what, almost 15 years ago in the psychedelic explorers guide.

Can you explain what microdosing is?

Yes.

...